May weighs Russia sanctions

An attack on an ex-spy has rocked UK-Russia relations, says Matthew Partridge.

887-May-634

Theresa May: furious language, but token measures
(Image credit: 2018 Getty Images)

Over the past five years Russian president Vladimir Putin has "meddled in a US presidential election, annexed Crimea, threatened nuclear war and mandated individual killings", of which the Salisbury poisonings of former spy Sergei Skripal, 66, and his daughter Yulia, 33, are suspected to be the latest, says Max Hastings in The Mail on Sunday. The pair were poisoned by a military-grade nerve agent developed by Russia, known as Novichok, reports the BBC.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Dr Matthew Partridge
Shares editor, MoneyWeek

Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.

He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.

Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.

As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.

Follow Matthew on Twitter: @DrMatthewPartri